Open AccessExpression of RARRES1 and AGBL2 and progression of conventional renal cell carcinoma
Author(s) -
Lehel Péterfi,
Dániel Bányai,
Maria V. Yusenko,
Thea Bjercke,
Gyula Kovács
Publication year - 2020
Publication title -
british journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.833
H-Index - 236
eISSN - 1532-1827
pISSN - 0007-0920
DOI - 10.1038/s41416-020-0798-6
Subject(s) - renal cell carcinoma , tissue microarray , medicine , metastasis , immunohistochemistry , oncology , proportional hazards model , cancer , carcinoma , clear cell renal cell carcinoma , risk factor , pathology
Approximately 15% of clinically localised conventional renal cell carcinoma (RCC) will develop metastasis within 5 years of follow-up. The aim of this study was to identify biomarkers predicting the postoperative tumour relapse.